Skip to main content
Erschienen in: Drug Safety 5/2008

01.05.2008 | Conference Paper

Cosmetovigilance

The ‘Beautiful’ Risk

verfasst von: Dr Ugo Moretti, Giampaolo Velo

Erschienen in: Drug Safety | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

A cosmetic is classically defined as any preparation that is applied to the skin, eyes, mouth, hair or nails for the purpose of cleansing, enhancing appearance, giving a pleasant smell or giving protection. Unlike drugs, which are used to treat or prevent a disease in the body, cosmetics are not thought to change or affect the body’s structure or functions. However, the distinction between drugs and cosmetics is sometimes not clear.
Regulations for cosmetic products primarily address the safety of products that may be used by large populations of healthy consumers. However, the efficacy and safety of cosmetic products are not reviewed or approved by national authorities before they are sold to the public.
The identification and analysis of adverse effects related to cosmetic products is a process that is currently still, to a large extent, industry driven. It is the responsibility of manufacturers to determine that products and ingredients are safe before they are marketed, and then to collect reports of adverse reactions. However, although the manufacturers do their best to monitor the safety profile of their products, we should consider that there is always a potential inherent conflict of interest.
Literatur
1.
Zurück zum Zitat EU Cosmetics directive 76/768/EEC art.1 EU Cosmetics directive 76/768/EEC art.1
2.
Zurück zum Zitat Federal Food, Drug, and Cosmetic Act. Chapter II, section 201 Federal Food, Drug, and Cosmetic Act. Chapter II, section 201
3.
Zurück zum Zitat Ly F, Soko AS, Dione DA, et al. Aesthetic problems associated with the cosmetic use of bleaching products. Int J Dermatol 2007 Oct; 46 Suppl. 1: 15–7PubMedCrossRef Ly F, Soko AS, Dione DA, et al. Aesthetic problems associated with the cosmetic use of bleaching products. Int J Dermatol 2007 Oct; 46 Suppl. 1: 15–7PubMedCrossRef
4.
Zurück zum Zitat Rguibi M, Belahsen R. Fattening practices among Moroccan Saharawi women. East Mediterr Health J 2006 Sep; 12 (5): 619–24PubMed Rguibi M, Belahsen R. Fattening practices among Moroccan Saharawi women. East Mediterr Health J 2006 Sep; 12 (5): 619–24PubMed
5.
Zurück zum Zitat Johansen JD. Fragrance contact allergy: a clinical review. Am J Clin Dermatol 2003; 4 (11): 789–98PubMedCrossRef Johansen JD. Fragrance contact allergy: a clinical review. Am J Clin Dermatol 2003; 4 (11): 789–98PubMedCrossRef
6.
Zurück zum Zitat Mehta SS, Reddy BS. Cosmetic dermatitis: current perspectives. Int J Dermatol 2003; 42 (7): 533–42PubMedCrossRef Mehta SS, Reddy BS. Cosmetic dermatitis: current perspectives. Int J Dermatol 2003; 42 (7): 533–42PubMedCrossRef
Metadaten
Titel
Cosmetovigilance
The ‘Beautiful’ Risk
verfasst von
Dr Ugo Moretti
Giampaolo Velo
Publikationsdatum
01.05.2008
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 5/2008
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200831050-00011

Weitere Artikel der Ausgabe 5/2008

Drug Safety 5/2008 Zur Ausgabe

Conference Paper

Phytotherapic Compounds